You can buy or sell Y-mAbs and other stocks, options, ETFs, and crypto commission-free!
Y-mAbs Therapeutics, Inc. Common Stock, also called Y-mAbs, is a clinical-stage biopharmaceutical company. Read More It develops novel antibody therapeutics for oncology targets. The company's services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Expected Mar 20, After Hours